title: Hydroxysteroid (17β) dehydrogenase X in human health and disease.
abstract: Hydroxysteroid (17β) dehydrogenase 10 (HSD10), the HSD17B10 gene product, is a mitochondrial NAD(+)-dependent dehydrogenase. There are two outstanding features of this vital enzyme: (a) the versatility of its catalytic endowment is attributed to the flexibility of its active site to accommodate diverse substrates such as steroids, fatty acids, bile acid, and xenobiotics; (b) its capacity to bind other proteins and peptides. For example, it tightly binds with three identical subunits to compose a homotetramer. The homotetramer then binds with two other proteins, namely, RNA (guanine-9-)methyl-transferase domain containing-1 and KIAA0391, to form mitochondrial RNase P. Furthermore, various HSD10 functions are inhibited when the enzyme is bound by amyloid-β peptide or estrogen receptor alpha. Missense mutations of HSD10 may cause neurodegeneration related to HSD10 deficiency, whereas a silent mutation of HSD10 results in mental retardation, choreoathetosis and abnormal behavior (MRXS10). The clinical condition of some HSD10 patients mimics mitochondrial disorders. Since normal HSD10 function is essential for brain cognitive activity, elevated levels of HSD10 found in brains of Alzheimer disease (AD) patients and mouse AD model might counterbalance the inhibition of HSD10 by amyloid-β peptide. The investigation of HSD10 may lead to a better understanding of AD pathogenesis.
authors.affiliation: Department of Neurochemistry, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA. songyu.yang@csi.cuny.edu
authors.forename: Song-Yu
authors.initials: SY
authors.lastname: Yang
authors.forename: Xue-Ying
authors.initials: XY
authors.lastname: He
authors.forename: David
authors.initials: D
authors.lastname: Miller
mesh_terms: D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000544:Alzheimer Disease / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000033:anatomy & histology / Q000201:enzymology; D020134:Catalytic Domain; D004314:Down Syndrome / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D038901:X-Linked Intellectual Disability / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D008928:Mitochondria / Q000201:enzymology; D008958:Models, Molecular; D015394:Molecular Structure; D020125:Mutation, Missense; D019636:Neurodegenerative Diseases / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D011485:Protein Binding; D011487:Protein Conformation; D021122:Protein Subunits / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013256:Steroids / Q000737:chemistry / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D021122:Protein Subunits; D013256:Steroids; D015094:3-Hydroxyacyl CoA Dehydrogenases; C108634:HSD17B10 protein, human